As of 2024-07-27, the EV/EBITDA ratio of Cipher Pharmaceuticals Inc (CPH.TO) is 13.02. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. CPH.TO's latest enterprise value is 155.25 mil CAD. CPH.TO's TTM EBITDA according to its financial statements is 11.92 mil CAD. Dividing these 2 quantities gives us the above CPH.TO EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 9.0x - 11.2x | 10.2x |
| Forward P/E multiples | 4.6x - 10.8x | 7.6x |
| Fair Price | 5.24 - 9.95 | 8.18 |
| Upside | -40.5% - 12.9% | -7.1% |
| Date | EV/EBITDA |
| 2024-07-25 | 14.33 |
| 2024-07-24 | 14.55 |
| 2024-07-23 | 14.31 |
| 2024-07-22 | 14.65 |
| 2024-07-19 | 14.55 |
| 2024-07-18 | 13.38 |
| 2024-07-17 | 13.36 |
| 2024-07-16 | 13.32 |
| 2024-07-15 | 13.42 |
| 2024-07-12 | 13.42 |
| 2024-07-11 | 13.38 |
| 2024-07-10 | 13.32 |
| 2024-07-09 | 13.42 |
| 2024-07-08 | 13.62 |
| 2024-07-05 | 13.48 |
| 2024-07-04 | 13.03 |
| 2024-07-03 | 13.17 |
| 2024-07-02 | 12.99 |
| 2024-06-28 | 13.09 |
| 2024-06-27 | 13.60 |
| 2024-06-26 | 13.56 |
| 2024-06-25 | 13.62 |
| 2024-06-24 | 13.62 |
| 2024-06-21 | 13.66 |
| 2024-06-20 | 13.40 |
| 2024-06-19 | 13.48 |
| 2024-06-18 | 13.32 |
| 2024-06-17 | 13.36 |
| 2024-06-14 | 13.78 |
| 2024-06-13 | 13.70 |
| 2024-06-12 | 14.06 |
| 2024-06-11 | 14.41 |
| 2024-06-10 | 14.51 |
| 2024-06-07 | 14.51 |
| 2024-06-06 | 14.55 |
| 2024-06-05 | 14.69 |
| 2024-06-04 | 14.61 |
| 2024-06-03 | 14.00 |
| 2024-05-31 | 14.23 |
| 2024-05-30 | 14.69 |
| 2024-05-29 | 14.47 |
| 2024-05-28 | 14.59 |
| 2024-05-27 | 14.21 |
| 2024-05-24 | 14.06 |
| 2024-05-23 | 13.78 |
| 2024-05-22 | 14.75 |
| 2024-05-21 | 14.47 |
| 2024-05-17 | 14.08 |
| 2024-05-16 | 14.35 |
| 2024-05-15 | 14.29 |